x

Search for a clinical trial

* (*) mandatory field

An Extension Treatment Protocol for Subjects who have Participated in a Phase 3 Study of Tivozanib vs. Sorafenib in Renal Cell Carcinoma (Protocol AV-951-09-301) - IT

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Aveo pharmaceuticals, inc.
    • Phase : III
  • Investigator of clinical trial

  • Dr Carlo GANINI
  • Ematologia
  • Dipartimento Oncoematologico
  • Fondazione IRCCS Policlinico San Matteo
  • Viale Camillo Golgi 19
  • 27100 PAVIA
  • ITALY
  • More information
  • Phone  : 39 0382 503595
  • Fax  : 39 0382 50225
  • Website
  • Contact secretary  :
Last update: October 2015

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.